Walleye Capital
RXST icon

Walleye Capital’s RxSight RXST Stock Holding History

Walleye Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
358,036
+43,420
+14% +$262K 0.01% 1648
2026
Q1 		$1.94M Buy
314,616
+226,871
+259% +$1.88M 0.01% 1490
2025
Q4 		$914K Sell
87,745
-50,664
-37% -$508K ﹤0.01% 2508
2025
Q3 		$1.24M Buy
138,409
+78,051
+129% +$685K ﹤0.01% 1925
2025
Q2 		$785K Sell
60,358
-137,497
-69% -$2.07M ﹤0.01% 2250
2025
Q1 		$5M Buy
197,855
+166,513
+531% +$4.95M 0.02% 785
2024
Q4 		$1.08M Sell
31,342
-98,345
-76% -$4.44M ﹤0.01% 2320
2024
Q3 		$6.41M Buy
129,687
+111,681
+620% +$5.72M 0.01% 996
2024
Q2 		$1.08M Sell
18,006
-6,755
-27% -$386K ﹤0.01% 2757
2024
Q1 		$1.28M Sell
24,761
-66,001
-73% -$3.24M ﹤0.01% 2354
2023
Q4 		$3.66M Buy
+90,762
New +$2.66M 0.01% 1316
2023
Q3 		– Sell
-15,679
Closed -$452K – 5268
2023
Q2 		$452K Buy
+15,679
New +$349K ﹤0.01% 2519

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Walleye Capital's RXST Position: Q2 2026 in Review

Walleye Capital increased its RxSight (RXST) stake by 14% in Q2 2026, buying an estimated $262K and bringing the position to 358,036 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #1648.

Walleye Capital first reported a position in RXST in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.41M in Q3 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Walleye Capital held 358,036 shares of RxSight worth $1.73M as of Q2 2026.
  • Walleye Capital bought 43,420 RxSight shares in Q2 2026, an estimated $262K.
  • RxSight made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1648 holding.
  • Walleye Capital first reported a position in RxSight in Q2 2023 and has held it in 12 quarters since.
  • Walleye Capital's RxSight position peaked at $6.41M in Q3 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.